These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9147421)

  • 21. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
    Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson P; Kaldor JM; Stewart GJ
    AIDS; 2000 Jan; 14(2):103-8. PubMed ID: 10708279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice.
    Picchio GR; Gulizia RJ; Mosier DE
    J Virol; 1997 Sep; 71(9):7124-7. PubMed ID: 9261448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
    Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
    AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene.
    Bratt G; Sandström E; Albert J; Samson M; Wahren B
    AIDS; 1997 Oct; 11(12):1415-9. PubMed ID: 9342063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
    Pasi KJ; Sabin CA; Jenkins PV; Devereux HL; Ononye C; Lee CA
    Br J Haematol; 2000 Oct; 111(1):136-42. PubMed ID: 11091193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
    Furci L; Scarlatti G; Burastero S; Tambussi G; Colognesi C; Quillent C; Longhi R; Loverro P; Borgonovo B; Gaffi D; Carrow E; Malnati M; Lusso P; Siccardi AG; Lazzarin A; Beretta A
    J Exp Med; 1997 Aug; 186(3):455-60. PubMed ID: 9236198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
    Fonseca LA; Reingold AL; Casseb JR; Brigido LF; Duarte AJ
    Int J Epidemiol; 1999 Dec; 28(6):1156-60. PubMed ID: 10661662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causal pathways for CCR5 genotype and HIV progression.
    Taylor JM; Wang Y; Ahdieh L; Chmiel JS; Detels R; Giorgi JV; Kaslow R; Kingsley L; Margolick J
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):160-71. PubMed ID: 10737431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.
    Knuchel MC; Spira TJ; Neumann AU; Xiao L; Rudolph DL; Phair J; Wolinsky SM; Koup RA; Cohen OJ; Folks TM; Lal RB
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):305-9. PubMed ID: 9519891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
    Huang Y; Paxton WA; Wolinsky SM; Neumann AU; Zhang L; He T; Kang S; Ceradini D; Jin Z; Yazdanbakhsh K; Kunstman K; Erickson D; Dragon E; Landau NR; Phair J; Ho DD; Koup RA
    Nat Med; 1996 Nov; 2(11):1240-3. PubMed ID: 8898752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
    Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Smith MW; Dean M; Carrington M; Huttley GA; O'Brien SJ
    Lancet; 1997 Sep; 350(9079):741; author reply 742. PubMed ID: 9291930
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 infection in an individual homozygous for the CCR5 deletion allele.
    Biti R; Ffrench R; Young J; Bennetts B; Stewart G; Liang T
    Nat Med; 1997 Mar; 3(3):252-3. PubMed ID: 9055842
    [No Abstract]   [Full Text] [Related]  

  • 39. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
    Philpott S; Weiser B; Tarwater P; Vermund SH; Kleeberger CA; Gange SJ; Anastos K; Cohen M; Greenblatt RM; Kovacs A; Minkoff H; Young MA; Miotti P; Dupuis M; Chen CH; Burger H
    J Infect Dis; 2003 Feb; 187(4):569-75. PubMed ID: 12599073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.